- Home
- NEO vs EOI Comparison
NEO vs EOI Comparison
Compare NEO & EOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- EOI
- Stock Information
- Founded
- NEO 2001
- EOI 2004
- Country
- NEO United States
- EOI United States
- Employees
- NEO N/A
- EOI N/A
- Industry
- NEO Precision Instruments
- EOI Finance/Investors Services
- Sector
- NEO Health Care
- EOI Finance
- Exchange
- NEO Nasdaq
- EOI Nasdaq
- Market Cap
- NEO 1.0B
- EOI 870.1M
- IPO Year
- NEO 1999
- EOI N/A
- Fundamental
- Price
- NEO $8.62
- EOI $21.10
- Analyst Decision
- NEO Buy
- EOI
- Analyst Count
- NEO 10
- EOI 0
- Target Price
- NEO $12.56
- EOI N/A
- AVG Volume (30 Days)
- NEO 2.9M
- EOI 83.6K
- Earning Date
- NEO 11-04-2025
- EOI 01-01-0001
- Dividend Yield
- NEO N/A
- EOI 7.19%
- EPS Growth
- NEO N/A
- EOI N/A
- EPS
- NEO N/A
- EOI N/A
- Revenue
- NEO $689,189,000.00
- EOI N/A
- Revenue This Year
- NEO $10.40
- EOI N/A
- Revenue Next Year
- NEO $10.11
- EOI N/A
- P/E Ratio
- NEO N/A
- EOI N/A
- Revenue Growth
- NEO 9.70
- EOI N/A
- 52 Week Low
- NEO $4.72
- EOI $14.36
- 52 Week High
- NEO $19.12
- EOI $18.88
- Technical
- Relative Strength Index (RSI)
- NEO 65.05
- EOI 42.15
- Support Level
- NEO $7.60
- EOI $21.23
- Resistance Level
- NEO $8.42
- EOI $21.44
- Average True Range (ATR)
- NEO 0.51
- EOI 0.18
- MACD
- NEO 0.02
- EOI -0.05
- Stochastic Oscillator
- NEO 74.12
- EOI 10.37
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About EOI Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest
Eaton Vance Enhanced Equity Income Fund offers mutual funds that invest across a wide array of equity, income, and alternative strategies. The primary investment objective of the fund is to provide current income, with a secondary objective of capital appreciation.